NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

睡眠呼吸暫停設備全球市場(~2026):類型/治療(CPAP/APAP/BPAP)/面部接口/口腔設備/配件),診斷(PSG/血氧計/活動記錄儀)系統),用戶(睡眠實驗室/醫院/家庭醫療),按地區

Sleep Apnea Devices Market by Type,Therapeutic (PAP (CPAP, APAP, BPAP) Facial Interfaces,Oral Appliances, Accessories), Diagnostic (PSG, Oximeter, Actigraphy Systems),End User (Sleep Laboratories & Hospitals, Home Care Settings)-Global Forecasts to 2026

出版商 MarketsandMarkets 商品編碼 1024773
出版日期 內容資訊 英文 315 Pages
訂單完成後即時交付
價格
睡眠呼吸暫停設備全球市場(~2026):類型/治療(CPAP/APAP/BPAP)/面部接口/口腔設備/配件),診斷(PSG/血氧計/活動記錄儀)系統),用戶(睡眠實驗室/醫院/家庭醫療),按地區 Sleep Apnea Devices Market by Type,Therapeutic (PAP (CPAP, APAP, BPAP) Facial Interfaces,Oral Appliances, Accessories), Diagnostic (PSG, Oximeter, Actigraphy Systems),End User (Sleep Laboratories & Hospitals, Home Care Settings)-Global Forecasts to 2026
出版日期: 2021年08月18日內容資訊: 英文 315 Pages
簡介

在預測期內,睡眠呼吸暫停設備市場將以6.9%的複合年增長率增長,從2021年的71億美元增長到 2026 年的 99 億美元。

大量未確診的睡眠呼吸暫停患者、對未經治療的不良反應認識的提高、口腔器械使用量的增加以及進入者的增加等因素正在推動市場的增長。另一方面,CPAP 設備成本高、轉診路線複雜、等待期長、產品召回等因素預計將在一定程度上抑制預測期內的市場增長。

按類型,治療設備部門的份額最大,預計在預測期內將以最高的複合年增長率增長。確診患者人數增加、治療設備引進增加以及報銷方案改善等因素正在推動該行業的增長。就最終用戶而言,睡眠測試實驗室/醫院部門擁有最大的市場份額。與此同時,預計家庭健康和個人部門在預測期內將顯示出最大的增長。

本報告探討了全球睡眠呼吸暫停設備市場、市場定義和概述、價值鏈、新型冠狀病毒感染 (COVID-19) 分析等市場影響因素,總結了法律和監管環境、技術/專利分析、流行病學分析、市場規模轉變/預測、按類型/最終用戶/地區/主要國家/地區、競爭環境和主要公司簡介等各種類別細分。

第 1 章介紹

第 2 章調查方法

第 3 章執行摘要

第 4 章重要考慮事項

第 5 章市場概覽

  • 市場動態
    • 促進因素
    • 抑制因素
    • 市場機會
    • 挑戰
  • COVID-19 的影響
  • 監管分析
  • 技術分析
  • 價格分析
  • 貿易分析
  • 專利分析
  • 價值鏈
  • 供應鏈
  • 生態系統
  • 波特五力分析
  • 影響客戶業務的趨勢
  • 範圍/場景

第 6 章睡眠呼吸暫停的流行病學評估

第 7 章睡眠呼吸暫停的替代療法

  • 呼氣氣道正壓
  • 舌下神經刺激
  • 口腔壓力療法 (OPT)
  • 睡姿療法

第 8 章市場分析/預測:按類型

  • 治療裝置
    • 氣道正壓裝置
    • 人臉界面
    • 配件
    • 口腔用具
    • 自適應伺服呼吸機
    • 其他
  • 診斷設備
    • 多導睡眠圖設備
    • 家用睡眠測試儀
    • 血氧儀
    • 活動記錄系統
    • 睡眠篩查裝置

第 9 章市場分析/預測:按最終用戶

  • 睡眠實驗室/醫院
  • 家庭醫療/個人

第 10 章市場分析/預測:按地區/主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 其他領域

第 11 章競爭形勢

  • 概述
  • 大公司的戰略
  • 收入分析
  • 市場份額分析
  • 企業評估象限
  • 企業評估象限:中小企業/初創企業
  • 競爭基準
  • 競爭場景/趨勢

第 12 章公司簡介

  • 主要公司
    • RESMED
    • KONINKLIJKE PHILIPS N.V.
    • FISHER & PAYKEL HEALTHCARE
    • INSPIRE MEDICAL SYSTEMS, INC.
    • SOMNOMED
    • OVENTUS MEDICAL
    • COMPUMEDICS
    • LOWENSTEIN MEDICAL TECHNOLOGY GMBH+CO. K.G.
    • DRIVE DEVILBISS HEALTHCARE
    • BMC MEDICAL CO., LTD.
    • BRAEBON MEDICAL CORPORATION
    • WHOLE YOU, INC.
    • PANTHERA DENTAL
    • MYERSON LLC
  • 其他龍頭企業
    • NIDEK MEDICAL INDIA
    • CURATIVE MEDICAL
    • LIVANOVA
    • INVACARE CORPORATION
    • ITAMAR MEDICAL LTD.
    • NIHON KOHDEN
    • NATUS MEDICAL INCORPORATED

第 13 章附錄

目錄
Product Code: MD 1181

The sleep apnea devices market is projected to reach USD 9.9 billion by 2026 from USD 7.1 billion in 2021, at a CAGR of 6.9% during the forecast period. Market growth is mainly driven by factors such as the large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, and an increasing number of companies venturing into the sleep apnea market. In contrast, the high cost of CPAP machines, complex referral pathways, long waiting periods, and product recalls are expected to limit market growth to a certain extent during the forecast period. The sleep apnea devices market is segmented based on type, end user and region.

"Therapeutic devices accounted for the largest share of the Sleep Apnea Devices Market and is expected to grow at the highest CAGR in the forecast period."

Based on type, the sleep apnea devices market is segmented into therapeutic and diagnostic devices. The therapeutic devices segment accounted for the largest market share and is also expected to register the highest CAGR during the forecast period. Growth in this segment can be attributed to the expanding pool of diagnosed sleep apnea patients, increasing adoption of sleep apnea therapeutic devices, and the improving reimbursement scenario for these devices.

"Sleep laboratories & hospitals account for the largest share of the Sleep Apnea Devices Market in 2020. The home care settings/individuals' segment is expected to grow at the fastest rate during the forecast period."

Based on end users, the sleep apnea devices market is segmented into sleep laboratories & hospitals and home care settings/individuals. The sleep laboratories & hospitals segment accounted for the largest share of the sleep apnea devices market. However, the home care settings/individuals' segment is estimated to grow at the highest CAGR during the forecast period. The increasing preference for home sleep testing by both patients and insurance companies, coupled with the favourable reimbursement scenario for home sleep testing.

"North America will dominate the market during the forecast period."

Geographically, the sleep apnea devices market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. In 2020, North America accounted for the largest share of the sleep apnea devices market. The large share of the North American market can be attributed to the increasing prevalence of the sleep apnea, growing awareness, wide usage of oral appliances for sleep apnea and of the leading players, such as ResMed, and Inspire Medical Systems, Inc., in the region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1: 55%, Tier 2: 40%, and Tier 3: 5%
  • By Designation - C-level: 37%, D-level: 48%, and Others: 15%
  • By Region - North America: 56%, Europe: 20%, Asia Pacific: 17%, and Rest of the World: 7%

List of Companies Profiled in the Report

  • ResMed (US)
  • Koninklijke Philips N.V. (Netherlands)
  • Fisher & Paykel Healthcare (New Zealand)
  • Inspire Medical Systems, Inc. (US)
  • Lowenstein Medical Technology GmbH + Co. K.G. (Germany)
  • SomnoMed (US)
  • Oventus Medical (Australia)
  • Compumedics (Australia)
  • Nihon Kohden (Japan)
  • Natus Medical (US)
  • Itamar Medical (Israel)
  • Whole You, Inc. (US)
  • Drive DeVilbiss Healthcare (US)
  • BMC Medical Co. Ltd. (China)
  • BRAEBON Medical (Canada)
  • Invacare Homecare (US)
  • Nidek Medical India (India)
  • Curative Medical (US)
  • LivaNova (UK)
  • Panthera Dental (Canada)
  • Myerson LLC (US)

Research Coverage:

This report provides a detailed picture of the global sleep apnea devices market. It aims at estimating the size and future growth potential of the market across different segments, such as type, end user and region. The report also analyzes factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total sleep apnea devices market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on sleep apnea devices offered by the top 14 players in the sleep apnea devices market. The report analyses the sleep apnea devices market by type, end user and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyses the markets for various sleep apnea devices across key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the sleep apnea devices market.
  • Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the sleep apnea devices market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • TABLE 1 INCLUSIONS & EXCLUSIONS OF THE STUDY
  • 1.3 MARKET SEGMENTATION
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 SLEEP APNEA DEVICES MARKET SEGMENTATION
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
    • TABLE 2 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 SLEEP APNEA DEVICES MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 5 SLEEP APNEA DEVICES MARKET - REVENUE SHARE ANALYSIS ILLUSTRATION: RESMED
    • FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF SLEEP APNEA DEVICES
    • FIGURE 7 CAGR PROJECTIONS
    • FIGURE 8 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.3.1 SECONDARY DATA
    • 2.3.2 PRIMARY DATA
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 ASSUMPTIONS FOR THE STUDY
  • 2.6 INDICATORS AND ASSUMPTIONS AND THEIR IMPACT ON THE STUDY
    • 2.6.1 COVID-19-SPECIFIC ASSUMPTIONS
  • 2.7 LIMITATIONS
  • 2.8 RISK ASSESSMENT
    • TABLE 3 RISK ASSESSMENT
  • 2.9 COVID-19 ECONOMIC ASSESSMENT
  • 2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • FIGURE 10 CRITERIA IMPACTING THE GLOBAL ECONOMY
    • FIGURE 11 RECOVERY SCENARIO OF THE GLOBAL ECONOMY

3 EXECUTIVE SUMMARY

    • FIGURE 12 SLEEP APNEA DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD BILLION)
    • FIGURE 13 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2021 VS. 2026 (USD BILLION)
    • FIGURE 14 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2021 VS. 2026 (USD BILLION)
    • FIGURE 15 SLEEP APNEA DEVICES MARKET, BY END USER, 2021 VS. 2026 (USD BILLION)
    • FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE SLEEP APNEA DEVICES MARKET

4 PREMIUM INSIGHTS

  • 4.1 SLEEP APNEA DEVICES MARKET OVERVIEW
    • FIGURE 17 LARGE POOL OF UNDIAGNOSED SLEEP APNEA PATIENTS TO DRIVE THE MARKET FOR SLEEP APNEA DEVICES
  • 4.2 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY TYPE (2020)
    • FIGURE 18 THERAPEUTIC DEVICES WILL CONTINUE TO DOMINATE THE ASIA PACIFIC SLEEP APNEA DEVICES MARKET IN 2020
  • 4.3 SLEEP APNEA DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 19 CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD
  • 4.4 SLEEP APNEA DEVICES MARKET, BY REGION (2019-2026)
    • FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE THE SLEEP APNEA DEVICES MARKET DURING THE FORECAST PERIOD
  • 4.5 SLEEP APNEA DEVICES MARKET: DEVELOPED VS. DEVELOPING MARKETS
    • FIGURE 21 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • TABLE 4 MARKET DYNAMICS: SLEEP APNEA DEVICES MARKET
    • 5.2.1 DRIVERS
      • 5.2.1.1 Large pool of undiagnosed sleep apnea patients
    • TABLE 5 GLOBAL PREVALENCE OF SLEEP APNEA IN 2019
    • TABLE 6 PREVALENCE OF SLEEP APNEA IN EUROPEAN COUNTRIES
      • 5.2.1.2 Favorable reimbursements and financial aid for sleep apnea devices and therapies
    • TABLE 7 REIMBURSEMENT CODES AND COSTS OF SOME SLEEP APNEA DEVICES BY RESMED
    • TABLE 8 ESTABLISHED CPT CODES PROVIDED BY ITAMAR MEDICAL
      • 5.2.1.3 Growing awareness about the ill effects of untreated sleep apnea
    • TABLE 9 INITIATIVES TO PROMOTE AWARENESS ABOUT THE ILL EFFECTS OF UNTREATED SLEEP APNEA
      • 5.2.1.4 Growing usage of oral appliances
    • TABLE 10 LIST OF ADVANCED ORAL APPLIANCES AVAILABLE FOR THE TREATMENT OF SLEEP APNEA
      • 5.2.1.5 Increasing number of companies venturing into the sleep apnea devices and oral appliances markets
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of CPAP machines
      • 5.2.2.2 Complex referral pathways, long waiting periods, and product recalls
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing demand for home sleep apnea tests (HSATs)
      • 5.2.3.2 Increasing focus on telemedicine, mHealth (mobile health), and artificial intelligence
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Lack of patient compliance
  • 5.3 COVID-19 IMPACT ON THE SLEEP APNEA DEVICES MARKET
    • FIGURE 22 COVID-19 IMPACT ON IN-FACILITY PATIENTS OF SLEEP APNEA
    • FIGURE 23 SLEEP CARE DELIVERY DURING COVID-19
    • FIGURE 24 SLEEP TESTING DURING THE COVID-19
    • TABLE 11 COVID-19 IMPACT ON THE SLEEP APNEA DEVICES MARKET
    • FIGURE 25 COVID-19 IMPACT ON THE REVENUES OF KEY PLAYERS' SLEEP APNEA DEVICE BUSINESSES
  • 5.4 REGULATORY ANALYSIS
    • TABLE 12 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING THE SLEEP APNEA DEVICES MARKET
    • 5.4.1 NORTH AMERICA
      • 5.4.1.1 US
    • TABLE 13 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 14 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.4.1.2 Canada
    • TABLE 15 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • FIGURE 26 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
    • 5.4.2 EUROPE
    • FIGURE 27 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
    • 5.4.3 ASIA PACIFIC
      • 5.4.3.1 Japan
        • 5.4.3.1.1 Revision of the Pharmaceutical Affairs Law (PAL) and implementation of the new PMD Act in Japan
    • TABLE 16 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
      • 5.4.3.2 China
    • TABLE 17 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.4.3.3 India
      • 5.4.3.4 Australia
        • 5.4.3.4.1 TGA device classification
  • 5.5 TECHNOLOGY ANALYSIS
    • TABLE 18 RECENT TECHNOLOGICAL ADVANCEMENTS IN SLEEP APNEA DEVICES
  • 5.6 PRICING ANALYSIS
    • TABLE 19 AVERAGE SELLING PRICES OF POSITIVE AIRWAY PRESSURE DEVICES
    • TABLE 20 AVERAGE SELLING PRICES OF FACIAL INTERFACES
    • TABLE 21 COST OF SLEEP APNEA TESTING
  • 5.7 TRADE ANALYSIS
    • 5.7.1 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2016-2020 (USD MILLION)
    • 5.7.2 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2016-2020 (USD MILLION)
  • 5.8 PATENT ANALYSIS
    • FIGURE 28 LIST OF MAJOR PATENTS FOR SLEEP APNEA DEVICES
    • FIGURE 29 REGIONAL ANALYSIS OF PATENTS GRANTED FOR THE SLEEP APNEA DEVICES MARKET, 2015-2021
    • TABLE 22 INDICATIVE LIST OF SLEEP APNEA DEVICE PATENTS
  • 5.9 VALUE CHAIN ANALYSIS
    • FIGURE 30 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
  • 5.10 SUPPLY CHAIN ANALYSIS
    • FIGURE 31 DIRECT DISTRIBUTION-THE PREFERRED STRATEGY OF PROMINENT COMPANIES
  • 5.11 ECOSYSTEM ANALYSIS
    • FIGURE 32 SLEEP APNEA DEVICES MARKET: ECOSYSTEM ANALYSIS
    • 5.11.1 ROLE IN THE ECOSYSTEM
    • FIGURE 33 KEY PLAYERS IN THE SLEEP APNEA DEVICES MARKET ECOSYSTEM
  • 5.12 PORTER'S FIVE FORCES ANALYSIS
    • 5.12.1 THREAT FROM NEW ENTRANTS
    • 5.12.2 BARGAINING POWER OF SUPPLIERS
    • 5.12.3 BARGAINING POWER OF BUYERS
    • 5.12.4 INTENSITY OF COMPETITIVE RIVALRY
    • 5.12.5 THREAT FROM SUBSTITUTES
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • 5.13.1 REVENUE SHIFT AND REVENUE POCKETS FOR SLEEP APNEA DEVICE MANUFACTURERS
    • 5.13.2 REVENUE SHIFT FOR SLEEP APNEA DEVICES
  • 5.14 RANGES/SCENARIOS
    • 5.14.1 PESSIMISTIC SCENARIO OF THE SLEEP APNEA DEVICES MARKET
    • 5.14.2 REALISTIC SCENARIO OF THE SLEEP APNEA DEVICES MARKET
    • 5.14.3 OPTIMISTIC SCENARIO OF THE SLEEP APNEA DEVICES MARKET

6 EPIDEMIOLOGICAL ASSESSMENT OF SLEEP APNEA

  • 6.1 INTRODUCTION
  • 6.2 EPIDEMIOLOGICAL ASSESSMENT
    • FIGURE 34 TOP TEN COUNTRIES WITH THE HIGHEST ESTIMATED NUMBER OF INDIVIDUALS WITH OBSTRUCTIVE SLEEP APNOEA BASED ON THE AMERICAN ACADEMY OF SLEEP MEDICINE 2012 CRITERIA
  • 6.3 PRESCRIPTION PATTERN ASSESSMENT
  • 6.4 ADHERENCE ASSESSMENT

7 ALTERNATE THERAPIES FOR SLEEP APNEA

  • 7.1 INTRODUCTION
  • 7.2 EXPIRATORY POSITIVE AIRWAY PRESSURE
  • 7.3 HYPOGLOSSAL NERVE STIMULATION
  • 7.4 ORAL PRESSURE THERAPY (OPT)
  • 7.5 POSITIONAL THERAPY

8 SLEEP APNEA DEVICES MARKET, BY TYPE

  • 8.1 INTRODUCTION
    • TABLE 23 SLEEP APNEA DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 8.2 THERAPEUTIC DEVICES
    • TABLE 24 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 25 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 8.2.1 POSITIVE AIRWAY PRESSURE DEVICES
    • TABLE 26 PAP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 27 PAP DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 8.2.1.1 Continuous positive airway pressure devices
        • 8.2.1.1.1 CPAP devices are considered the gold standard in sleep apnea treatment-a key factor driving market growth
    • TABLE 28 CPAP DEVICES OFFERED BY KEY PLAYERS
    • TABLE 29 CPAP DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 8.2.1.2 Automatic positive airway pressure devices
        • 8.2.1.2.1 Demand for APAP devices has increased significantly in the last few years due to patient non-compliance with CPAP devices
    • TABLE 30 APAP DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 8.2.1.3 Bilevel positive airway pressure devices
        • 8.2.1.3.1 BPAP devices are generally costlier and more complex than other available PAP devices, which is a major reason for their low adoption
    • TABLE 31 BPAP DEVICES OFFERED BY KEY PLAYERS
    • TABLE 32 BPAP DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 8.2.2 FACIAL INTERFACES
    • TABLE 33 FACIAL INTERFACES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 34 FACIAL INTERFACES MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 8.2.2.1 Masks
    • TABLE 35 MASKS OFFERED BY KEY PLAYERS
    • TABLE 36 MASKS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 37 MASKS MARKET, BY REGION, 2019-2026 (USD MILLION)
        • 8.2.2.1.1 Full-face masks
  • 8.2.2.1.1.1 Full-face masks offer the greatest chance of compliance for mouth breathers or patients who struggle to breathe through their nose
    • TABLE 38 FULL-FACE MASKS OFFERED BY KEY PLAYERS
    • TABLE 39 FULL-FACE MASKS MARKET, BY REGION, 2019-2026 (USD MILLION)
        • 8.2.2.1.2 Nasal pillow masks
  • 8.2.2.1.2.1 Greater patient compliance is one of the key factors driving the demand for nasal pillow masks
    • TABLE 40 NASAL PILLOW MASKS OFFERED BY KEY PLAYERS
    • TABLE 41 NASAL PILLOW MASKS MARKET, BY REGION, 2019-2026 (USD MILLION)
        • 8.2.2.1.3 Nasal masks
  • 8.2.2.1.3.1 Nasal masks have an advantage over full-face masks in that they do not obstruct the patients' view and allow patients to wear spectacles
    • TABLE 42 NASAL MASKS MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 8.2.2.2 Cushions
        • 8.2.2.2.1 Different product launches in the past few years to drive market growth
    • TABLE 43 CUSHIONS OFFERED BY KEY PLAYERS
    • TABLE 44 CUSHIONS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 8.2.3 ACCESSORIES
    • TABLE 45 ACCESSORIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 46 ACCESSORIES MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 8.2.3.1 Humidifier accessories
        • 8.2.3.1.1 Humidifiers help to open the airways, decrease congestion, and encourage clearer breathing
    • TABLE 47 HUMIDIFIER ACCESSORIES MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 8.2.3.2 Power accessories
        • 8.2.3.2.1 Power accessories help to manage uninterrupted sleep apnea therapy in the absence of a power supply
    • TABLE 48 POWER ACCESSORIES MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 8.2.3.3 Transportation accessories
        • 8.2.3.3.1 The convenience associated with transportation accessories to drive market growth
    • TABLE 49 TRANSPORTATION ACCESSORIES MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 8.2.3.4 Communication accessories
        • 8.2.3.4.1 Communication accessories help monitor sleep apnea symptoms through teleconsultations
    • TABLE 50 COMMUNICATION ACCESSORIES MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 8.2.3.5 Chin restraints
        • 8.2.3.5.1 Chin restraints hold the mouth in position during therapy- an essential part of sleep apnea management
    • TABLE 51 CHIN RESTRAINTS MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 8.2.3.6 Other accessories
    • TABLE 52 OTHER ACCESSORIES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 8.2.4 ORAL APPLIANCES
    • TABLE 53 ORAL APPLIANCES OFFERED BY KEY PLAYERS
    • TABLE 54 ORAL APPLIANCES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 55 ORAL APPLIANCES MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 8.2.4.1 Mandibular advancement devices
        • 8.2.4.1.1 Mandibular advancement devices are primarily used for the treatment of mild OSA and snoring
    • TABLE 56 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 8.2.4.2 Tongue-retaining devices
        • 8.2.4.2.1 TRDs are less expensive and help reduce both snoring and sleep apnea
    • TABLE 57 TONGUE-RETAINING DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 8.2.5 ADAPTIVE SERVO-VENTILATORS
      • 8.2.5.1 Improving clinical outcomes associated with ASVs to fuel market growth
    • TABLE 58 ADAPTIVE SERVO-VENTILATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 8.2.6 OTHER THERAPEUTIC DEVICES
    • TABLE 59 OTHER THERAPEUTIC DEVICES OFFERED BY THE KEY PLAYERS
    • TABLE 60 OTHER THERAPEUTIC DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 8.3 DIAGNOSTIC DEVICES
    • TABLE 61 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 62 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 8.3.1 POLYSOMNOGRAPHY DEVICES
    • TABLE 63 PSG DEVICES OFFERED BY KEY PLAYERS
    • TABLE 64 PSG DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 65 PSG DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 8.3.1.1 Ambulatory PSG devices
        • 8.3.1.1.1 The demand for ambulatory PSG devices has increased due to their cost-effectiveness and convenience for patients
    • TABLE 66 AMBULATORY PSG DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 8.3.1.2 Clinical PSG devices
        • 8.3.1.2.1 These devices require constant supervision-a key factor limiting market growth
    • TABLE 67 CLINICAL PSG DEVICES OFFERED BY KEY PLAYERS
    • TABLE 68 CLINICAL PSG DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 8.3.2 HOME SLEEP TESTING DEVICES
      • 8.3.2.1 Cost-effectiveness and comfort of home sleep testing are expected to drive the growth of home sleep testing devices
    • TABLE 69 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 8.3.3 OXIMETERS
    • TABLE 70 OXIMETERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 71 OXIMETERS MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 8.3.3.1 Fingertip oximeters
        • 8.3.3.1.1 A major drawback of fingertip oximeters is that they cannot provide precise readings if the patient's hand is injured or if there is slow blood flow due to blood clotting or any injury
    • TABLE 72 FINGERTIP OXIMETERS OFFERED BY KEY PLAYERS
    • TABLE 73 FINGERTIP OXIMETERS MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 8.3.3.2 Handheld oximeters
        • 8.3.3.2.1 Handheld oximeters are more expensive than fingertip and wrist oximeters
    • TABLE 74 HANDHELD OXIMETERS OFFERED BY KEY PLAYERS
    • TABLE 75 HANDHELD OXIMETERS MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 8.3.3.3 Wrist-worn oximeters
        • 8.3.3.3.1 The global demand for wrist-worn oximeters is propelled by their small size, long-term usage, need for overnight monitoring, and their portability
    • TABLE 76 WRIST-WORN OXIMETERS OFFERED BY KEY PLAYERS
    • TABLE 77 WRIST-WORN OXIMETERS MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 8.3.3.4 Tabletop oximeters
        • 8.3.3.4.1 Tabletop oximeters account for a smaller share of the market than handheld or wrist-worn oximeters due to their higher cost and fewer applications
    • TABLE 78 TABLETOP OXIMETERS OFFERED BY KEY PLAYERS
    • TABLE 79 TABLETOP OXIMETERS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 8.3.4 ACTIGRAPHY SYSTEMS
      • 8.3.4.1 Increasing focus on assessing actimeter performance contributes to market growth
    • TABLE 80 ACTIGRAPHY SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 8.3.5 SLEEP SCREENING DEVICES
      • 8.3.5.1 Increasing preference for home-based testing for its efficacy and comfort are driving the use of sleep screening devices
    • TABLE 81 SLEEP SCREENING DEVICES OFFERED BY KEY PLAYERS
    • TABLE 82 SLEEP SCREENING DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)

9 SLEEP APNEA DEVICES MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 83 SLEEP APNEA DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.2 SLEEP LABORATORIES & HOSPITALS
    • 9.2.1 ADVANCED INFRASTRUCTURE AND EXPENDITURE OF SLEEP LABORATORIES & HOSPITALS TO DRIVE GROWTH IN THIS END-USER SEGMENT
    • TABLE 84 SLEEP APNEA DEVICES MARKET FOR SLEEP LABORATORIES & HOSPITALS, BY REGION, 2019-2026 (USD MILLION)
  • 9.3 HOME CARE SETTINGS/INDIVIDUALS
    • 9.3.1 INCREASING PATIENT PREFERENCE FOR HOME-BASED SLEEP TESTS TO FUEL MARKET GROWTH
    • TABLE 85 SLEEP APNEA DEVICES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY REGION, 2019-2026 (USD MILLION)

10 SLEEP APNEA DEVICES MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • FIGURE 35 NORTH AMERICA: SLEEP APNEA DEVICES MARKET SNAPSHOT
    • TABLE 86 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 87 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 88 NORTH AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 89 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 90 NORTH AMERICA: FACIAL INTERFACES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 91 NORTH AMERICA: MASKS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 92 NORTH AMERICA: ACCESSORIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 93 NORTH AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 94 NORTH AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 95 NORTH AMERICA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 96 NORTH AMERICA: OXIMETERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 97 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Availability of grants and funds and the increasing trend of home sleep testing are expected to drive market growth in the US during the forecast period
    • TABLE 98 KEY SLEEP APNEA PRODUCTS IN THE US
    • TABLE 99 US: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 100 US: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 101 US: PAP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 102 US: FACIAL INTERFACES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 103 US: MASKS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 104 US: ACCESSORIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 105 US: ORAL APPLIANCES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 106 US: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 107 US: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 108 US: OXIMETERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 109 US: SLEEP APNEA DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Rising number of research grants and health programs to drive market growth in Canada
    • TABLE 110 KEY SLEEP APNEA PRODUCTS IN CANADA
    • TABLE 111 CANADA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 112 CANADA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 113 CANADA: PAP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 114 CANADA: FACIAL INTERFACES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 115 CANADA: MASKS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 116 CANADA: ACCESSORIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 117 CANADA: ORAL APPLIANCES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 118 CANADA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 119 CANADA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 120 CANADA: OXIMETERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 121 CANADA: SLEEP APNEA DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 122 EUROPE: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 123 EUROPE: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 124 EUROPE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 125 EUROPE: PAP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 126 EUROPE: FACIAL INTERFACES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 127 EUROPE: MASKS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 128 EUROPE: ACCESSORIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 129 EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 130 EUROPE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 131 EUROPE: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 132 EUROPE: OXIMETERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 133 EUROPE: SLEEP APNEA DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Prevalence of OSA in Germany is among the highest in Europe- a key factor driving market growth
    • TABLE 134 KEY SLEEP APNEA PRODUCTS IN GERMANY
    • TABLE 135 GERMANY: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 136 GERMANY: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 137 GERMANY: PAP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 138 GERMANY: FACIAL INTERFACES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 139 GERMANY: MASKS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 140 GERMANY: ACCESSORIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 141 GERMANY: ORAL APPLIANCES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 142 GERMANY: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 143 GERMANY: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 144 GERMANY: OXIMETERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 145 GERMANY: SLEEP APNEA DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.2 FRANCE
      • 10.3.2.1 Rising geriatric population to increase the incidence of sleep apnea in France
    • TABLE 146 FRANCE: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 147 FRANCE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 148 FRANCE: PAP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 149 FRANCE: FACIAL INTERFACES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 150 FRANCE: MASKS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 151 FRANCE: ACCESSORIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 152 FRANCE: ORAL APPLIANCES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 153 FRANCE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 154 FRANCE: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 155 FRANCE: OXIMETERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 156 FRANCE: SLEEP APNEA DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.3 UK
      • 10.3.3.1 Rising awareness initiatives and sleep service groups to support market growth in the UK
    • TABLE 157 UK: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 158 UK: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 159 UK: PAP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 160 UK: FACIAL INTERFACES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 161 UK: MASKS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 162 UK: ACCESSORIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 163 UK: ORAL APPLIANCES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 164 UK: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 165 UK: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 166 UK: OXIMETERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 167 UK: SLEEP APNEA DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 High prevalence of sleep apnea and increasing awareness to drive market growth in Italy
    • TABLE 168 PREVALENCE OF OBSTRUCTIVE SLEEP APNEA FOR THE POPULATION IN ITALY, 2018
    • TABLE 169 ITALY: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 170 ITALY: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 171 ITALY: PAP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 172 ITALY: FACIAL INTERFACES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 173 ITALY: MASKS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 174 ITALY: ACCESSORIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 175 ITALY: ORAL APPLIANCES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 176 ITALY: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 177 ITALY: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 178 ITALY: OXIMETERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 179 ITALY: SLEEP APNEA DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Increasing initiatives for awareness by regional organizations are driving the market growth in Spain
    • TABLE 180 SPAIN: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 181 SPAIN: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 182 SPAIN: PAP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 183 SPAIN: FACIAL INTERFACES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 184 SPAIN: MASKS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 185 SPAIN: ACCESSORIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 186 SPAIN: ORAL APPLIANCES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 187 SPAIN: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 188 SPAIN: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 189 SPAIN: OXIMETERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 190 SPAIN: SLEEP APNEA DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 191 ROE: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 192 ROE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 193 ROE: PAP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 194 ROE: FACIAL INTERFACES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 195 ROE: MASKS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 196 ROE: ACCESSORIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 197 ROE: ORAL APPLIANCES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 198 ROE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 199 ROE: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 200 ROE: OXIMETERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 201 ROE: SLEEP APNEA DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 36 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET SNAPSHOT
    • TABLE 202 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 203 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 204 ASIA PACIFIC: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 205 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 206 ASIA PACIFIC: FACIAL INTERFACES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 207 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 208 ASIA PACIFIC: ACCESSORIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 209 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 210 ASIA PACIFIC: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 211 ASIA PACIFIC: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 212 ASIA PACIFIC: OXIMETERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 213 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Changing reimbursement scenario and increasing demand for cloud-connected sleep apnea therapeutic devices to drive market growth in Japan
    • TABLE 214 JAPAN: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 215 JAPAN: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 216 JAPAN: PAP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 217 JAPAN: FACIAL INTERFACES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 218 JAPAN: MASKS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 219 JAPAN: ACCESSORIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 220 JAPAN: ORAL APPLIANCES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 221 JAPAN: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 222 JAPAN: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 223 JAPAN: OXIMETERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 224 JAPAN: SLEEP APNEA DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Growing adult obesity rates and expanding geriatric population to increase the prevalence of sleep apnea in China
    • TABLE 225 CHINA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 226 CHINA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 227 CHINA: PAP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 228 CHINA: FACIAL INTERFACES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 229 CHINA: MASKS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 230 CHINA: ACCESSORIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 231 CHINA: ORAL APPLIANCES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 232 CHINA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 233 CHINA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 234 CHINA: OXIMETERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 235 CHINA: SLEEP APNEA DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.3 AUSTRALIA
      • 10.4.3.1 High prevalence of sleep apnea and growing number of awareness programs to drive market growth in Australia
    • TABLE 236 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 237 AUSTRALIA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 238 AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 239 AUSTRALIA: FACIAL INTERFACES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 240 AUSTRALIA: MASKS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 241 AUSTRALIA: ACCESSORIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 242 AUSTRALIA: ORAL APPLIANCES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 243 AUSTRALIA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 244 AUSTRALIA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 245 AUSTRALIA: OXIMETERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 246 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.4 REST OF ASIA PACIFIC
    • TABLE 247 ROAPAC: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 248 ROAPAC: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 249 ROAPAC: PAP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 250 ROAPAC: FACIAL INTERFACES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 251 ROAPAC: MASKS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 252 ROAPAC: ACCESSORIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 253 ROAPAC: ORAL APPLIANCES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 254 ROAPAC: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 255 ROAPAC: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 256 ROAPAC: OXIMETERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 257 ROAPAC: SLEEP APNEA DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.5 REST OF THE WORLD
    • TABLE 258 ROW: SLEEP APNEA DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 259 ROW: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 260 ROW: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 261 ROW: PAP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 262 ROW: FACIAL INTERFACES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 263 ROW: MASKS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 264 ROW: ACCESSORIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 265 ROW: ORAL APPLIANCES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 266 ROW: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 267 ROW: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 268 ROW: OXIMETERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 269 ROW: SLEEP APNEA DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.5.1 LATIN AMERICA
      • 10.5.1.1 Increasing obesity rate in latam has resulted in increased prevalence of sleep apnea
    • TABLE 270 LATAM: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 271 LATAM: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 272 LATAM: PAP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 273 LATAM: FACIAL INTERFACES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 274 LATAM: MASKS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 275 LATAM: ACCESSORIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 276 LATAM: ORAL APPLIANCES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 277 LATAM: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 278 LATAM: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 279 LATAM: OXIMETERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 280 LATAM: SLEEP APNEA DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.5.2 MIDDLE EAST & AFRICA
      • 10.5.2.1 Dearth of awareness about sleep apnea restrains market growth in the Middle East & Africa
    • TABLE 281 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 282 MIDDLE EAST & AFRICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 283 MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 284 MIDDLE EAST & AFRICA: FACIAL INTERFACES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 285 MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 286 MIDDLE EAST & AFRICA: ACCESSORIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 287 MIDDLE EAST & AFRICA: ORAL APPLIANCES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 288 MIDDLE EAST & AFRICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 289 MIDDLE EAST & AFRICA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 290 MIDDLE EAST & AFRICA: OXIMETERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 291 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF THE STRATEGIES ADOPTED BY KEY PLAYERS IN THE SLEEP APNEA DEVICES MARKET
  • 11.3 REVENUE ANALYSIS
    • FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN THE SLEEP APNEA DEVICES MARKET
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 38 SLEEP APNEA DEVICES MARKET SHARE ANALYSIS, 2020
    • TABLE 292 SLEEP APNEA DEVICES MARKET: DEGREE OF COMPETITION
  • 11.5 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS)
    • 11.5.1 STARS
    • 11.5.2 PERVASIVE PLAYERS
    • 11.5.3 EMERGING LEADERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 39 SLEEP APNEA DEVICES MARKET (GLOBAL): COMPANY EVALUATION QUADRANT, 2020
  • 11.6 COMPANY EVALUATION QUADRANT (SMES/STARTUPS)
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
    • FIGURE 40 SLEEP APNEA DEVICES MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
  • 11.7 COMPETITIVE BENCHMARKING
    • 11.7.1 COMPANY PRODUCT FOOTPRINT (21 COMPANIES)
    • 11.7.2 COMPANY REGIONAL FOOTPRINT
    • 11.7.3 COMPANY FOOTPRINT
  • 11.8 COMPETITIVE SCENARIO AND TRENDS
    • 11.8.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 293 PRODUCT LAUNCHES & APPROVALS, JANUARY 2018-JULY 2021
    • 11.8.2 DEALS
    • TABLE 294 DEALS, JANUARY 2018-JULY 2021
    • 11.8.3 OTHER DEVELOPMENTS
    • TABLE 295 OTHER DEVELOPMENTS, JANUARY 2018-JULY 2021

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products/Solutions Offered, Recent Developments, SWOT Analysis, Winning Imperatives, Current Focus and Strategies, Threat From Competition, Right to Win)**
    • 12.1.1 RESMED
    • TABLE 296 RESMED: BUSINESS OVERVIEW
    • FIGURE 41 RESMED: COMPANY SNAPSHOT (2020)
    • 12.1.2 KONINKLIJKE PHILIPS N.V.
    • TABLE 297 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
    • FIGURE 42 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020)
    • 12.1.3 FISHER & PAYKEL HEALTHCARE
    • TABLE 298 FISHER & PAYKEL HEALTHCARE: BUSINESS OVERVIEW
    • FIGURE 43 FISHER & PAYKEL HEALTHCARE: COMPANY SNAPSHOT (2020)
    • 12.1.4 INSPIRE MEDICAL SYSTEMS, INC.
    • TABLE 299 INSPIRE MEDICAL SYSTEMS, INC.: BUSINESS OVERVIEW
    • FIGURE 44 INSPIRE MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2020)
    • 12.1.5 SOMNOMED
    • TABLE 300 SOMNOMED: BUSINESS OVERVIEW
    • FIGURE 45 SOMNOMED: COMPANY SNAPSHOT (2020)
    • 12.1.6 OVENTUS MEDICAL
    • TABLE 301 OVENTUS MEDICAL: BUSINESS OVERVIEW
    • FIGURE 46 OVENTUS MEDICAL: COMPANY SNAPSHOT (2020)
    • 12.1.7 COMPUMEDICS
    • TABLE 302 COMPUMEDICS: BUSINESS OVERVIEW
    • FIGURE 47 COMPUMEDICS: COMPANY SNAPSHOT (2020)
    • 12.1.8 LOWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. K.G.
    • TABLE 303 LOWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. K.G.: BUSINESS OVERVIEW
    • 12.1.9 DRIVE DEVILBISS HEALTHCARE
    • TABLE 304 DRIVE DEVILBISS HEALTHCARE: BUSINESS OVERVIEW
    • 12.1.10 BMC MEDICAL CO., LTD.
    • TABLE 305 BMC MEDICAL CO., LTD.: BUSINESS OVERVIEW
    • 12.1.11 BRAEBON MEDICAL CORPORATION
    • TABLE 306 BRAEBON MEDICAL CORPORATION: BUSINESS OVERVIEW
    • 12.1.12 WHOLE YOU, INC.
    • TABLE 307 WHOLE YOU, INC.: BUSINESS OVERVIEW
    • 12.1.13 PANTHERA DENTAL
    • TABLE 308 PANTHERA DENTAL: BUSINESS OVERVIEW
    • 12.1.14 MYERSON LLC
    • TABLE 309 MYERSON LLC: BUSINESS OVERVIEW
  • *Business Overview, Products/Solutions Offered, Recent Developments, SWOT Analysis, Winning Imperatives, Current Focus and Strategies, Threat From Competition, Right to Win might not be captured in case of unlisted companies.
  • 12.2 OTHER PLAYERS
    • 12.2.1 NIDEK MEDICAL INDIA
    • TABLE 310 NIDEK MEDICAL INDIA: COMPANY OVERVIEW
    • 12.2.2 CURATIVE MEDICAL
    • TABLE 311 CURATIVE MEDICAL: COMPANY OVERVIEW
    • 12.2.3 LIVANOVA
    • TABLE 312 LIVANOVA: COMPANY OVERVIEW
    • 12.2.4 INVACARE CORPORATION
    • TABLE 313 INVACARE CORPORATION: COMPANY OVERVIEW
    • 12.2.5 ITAMAR MEDICAL LTD.
    • TABLE 314 ITAMAR MEDICAL LTD.: COMPANY OVERVIEW
    • 12.2.6 NIHON KOHDEN
    • TABLE 315 NIHON KOHDEN: COMPANY OVERVIEW
    • 12.2.7 NATUS MEDICAL INCORPORATED
    • TABLE 316 NATUS MEDICAL INCORPORATED: COMPANY OVERVIEW

13 APPENDIX

  • 13.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 13.2 DISCUSSION GUIDE
  • 13.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4 AVAILABLE CUSTOMIZATIONS
  • 13.5 RELATED REPORTS
  • 13.6 AUTHOR DETAILS